161 related articles for article (PubMed ID: 38792317)
1. Validation of a New Scoring Method to Assess the Efficacy of Rapid Initiation and Titration of Combination Pharmacotherapy for Patients Hospitalized with Acute Decompensated Heart Failure with Reduced and Mildly Reduced Ejection Fraction.
Asano T; Maeno Y; Nakano M; Taguri M; Miyasaka M; Nakai D; Miyazaki I; Nasu T; Tanimoto S; Masuda N; Morino Y; Isshiki T; Ogata N
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792317
[No Abstract] [Full Text] [Related]
2. Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.
Balakumaran K; Patil A; Marsh S; Ingrassia J; Kuo CL; Jacoby DL; Arora S; Soucier R
Int J Cardiol Heart Vasc; 2019 Mar; 22():1-5. PubMed ID: 30480083
[TBL] [Abstract][Full Text] [Related]
3. Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients - A Report From the West Tokyo Heart Failure Registry.
Ohata T; Niimi N; Shiraishi Y; Nakatsu F; Umemura I; Kohno T; Nagatomo Y; Takei M; Ono T; Sakamoto M; Nakano S; Fukuda K; Kohsaka S; Yoshikawa T
Circ J; 2023 Dec; 88(1):22-30. PubMed ID: 37914282
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction.
Wongsalap Y; Poolpun D; Keawhai K; Kitpluem N; Pansiri P; Malaimat S; Senthong V; Kengkla K
Chronic Dis Transl Med; 2023 Jun; 9(2):154-163. PubMed ID: 37305111
[TBL] [Abstract][Full Text] [Related]
5. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.
Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE
Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950
[TBL] [Abstract][Full Text] [Related]
6. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM
J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry.
Harikrishnan S; Bahl A; Roy A; Mishra A; Prajapati J; Manjunath CN; Sethi R; Guha S; Satheesh S; Dhaliwal RS; Sarma M; Ganapathy S; Jeemon P;
ESC Heart Fail; 2022 Dec; 9(6):3898-3908. PubMed ID: 36214477
[TBL] [Abstract][Full Text] [Related]
8. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J
JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135
[TBL] [Abstract][Full Text] [Related]
9. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients.
Matsukawa R; Okahara A; Tokutome M; Itonaga J; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Kawai S; Ogawa K; Matsuura H; Mukai Y
ESC Heart Fail; 2023 Dec; 10(6):3352-3363. PubMed ID: 37671603
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
[TBL] [Abstract][Full Text] [Related]
11. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
[TBL] [Abstract][Full Text] [Related]
12. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk.
Ambrosy AP; Chang AJ; Davison B; Voors A; Cohen-Solal A; Damasceno A; Kimmoun A; Lam CSP; Edwards C; Tomasoni D; Gayat E; Filippatos G; Saidu H; Biegus J; Celutkiene J; Ter Maaten JM; Čerlinskaitė-Bajorė K; Sliwa K; Takagi K; Metra M; Novosadova M; Barros M; Adamo M; Pagnesi M; Arrigo M; Chioncel O; Diaz R; Pang PS; Ponikowski P; Cotter G; Mebazaa A
JACC Heart Fail; 2024 May; ():. PubMed ID: 38739123
[TBL] [Abstract][Full Text] [Related]
13. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G
Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585
[TBL] [Abstract][Full Text] [Related]
14. Economic Modeling Analysis of an Intensive GDMT Optimization Program in Hospitalized Heart Failure Patients.
Dixit NM; Parikh NU; Ziaeian B; Fonarow GC
Circ Heart Fail; 2023 Dec; 16(12):e011218. PubMed ID: 37929591
[TBL] [Abstract][Full Text] [Related]
15. Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
ESC Heart Fail; 2023 Feb; 10(1):223-233. PubMed ID: 36193578
[TBL] [Abstract][Full Text] [Related]
16. Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand.
Teng TK; Tay WT; Ouwerkerk W; Tromp J; Richards AM; Gamble G; Greene SJ; Yiu KH; Poppe K; Ling LH; Lund M; Sim D; Devlin G; Loh SY; Troughton R; Ren QW; Jaufeerally F; Lee SGS; Tan RS; Soon DKN; Leong G; Ong HY; Yeo DPS; Lam CSP; Doughty RN
ESC Heart Fail; 2023 Apr; 10(2):1280-1293. PubMed ID: 36722315
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of guideline-directed medical therapy in patients with heart failure on regular hemodialysis.
Kishihara M; Takada T; Jujo K; Shirotani S; Abe T; Yoshida A; Watanabe S; Hagiwara N
Int J Cardiol; 2023 Jan; 370():250-254. PubMed ID: 36270495
[TBL] [Abstract][Full Text] [Related]
18. The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice.
Bánfi-Bacsárdi F; Muk B; Pilecky D; Duray GZ; Kiss RG; Nyolczas N
Cardiology; 2023; 148(1):27-37. PubMed ID: 36470212
[TBL] [Abstract][Full Text] [Related]
19. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Oman: utilization, reasons behind non-prescribing, and dose optimization.
Al-Aghbari S; Al-Maqbali JS; Alawi AMA; Za'abi MA; Al-Zakwani I
Pharm Pract (Granada); 2022; 20(2):2642. PubMed ID: 35919792
[TBL] [Abstract][Full Text] [Related]
20. Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
Izumi K; Kohno T; Goda A; Takeuchi S; Shiraishi Y; Saji M; Nagatomo Y; Tanaka TD; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
Int J Cardiol; 2023 Jan; 370():255-262. PubMed ID: 36270494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
